尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the full record of transactions filed by Baxter Richard B, Director. Director active across 1 company, notably Pelthos Therapeutics Inc.. Cumulatively, 1 filings have been logged. History available since 2 July 2025. The latest transaction was filed on 2 July 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Richard B. Baxter is a Board Member at Pelthos Therapeutics Inc. He brings his expertise in corporate governance and strategy. As a board member, Baxter contributes to overseeing operations and guiding the company's strategic direction, ensuring it meets its growth objectives.